Clinical Trial Update: Nitrite Infusion in High Risk Patients Undergoing Cardiopulmonary Bypass [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating nitrite infusion in high-risk patients undergoing cardiopulmonary bypass has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Nitrite infusion (sodium nitrite)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Acute Kidney Injury | Phase 3 | Status: WITHDRAWN